1.Effect of Dahuang Mudan Decoction on Mice Colitis Induced by Trinitrobenzene Sulfonic Acid
Chenmei ZHOU ; Qing WANG ; Lian ZHOU ; Liuying CAO ; Ruiyan LIANG ; Peixun WANG
Traditional Chinese Drug Research & Clinical Pharmacology 1993;0(04):-
Objective To study the effect of Dahuang Mudan Decoction on experimental colitis induced by trinitrobenzene sulfonic acid(TNBS)in mice and to explore its mechanism.Methods Mice colitis model was established by rectal administration of trinitrobenzene sulfonic acid.Disease activity index(DAI)and histological scores were assessed,the serum level of TNF-? was detected by ELISA.Results Dahuang Mudan Decoction reduced DAI and histological scores in mice,and alleviate inflammation in colonic tissue.It also significantly decreased mice serum TNF-? level.Conclusions Dahuang Mudan Decoction shows positive therapeutic efficacy on mice colitis induced by trinitrobenzene sulfonic acid,and its mechanism may be involved in inhibiting the production of TNF-?.
2. Multicenter investigation of extracorporeal membrane oxygenation application in pediatric intensive care unit in China
Gangfeng YAN ; Xiaodi CAI ; Chengbin ZHOU ; Xiaoyang HONG ; Ying WANG ; Chenmei ZHANG ; Zihao YANG ; Yucai ZHANG ; Yun CUI ; Yanqin CUI ; Yibing CHENG ; Suyun QIAN ; Pengfei ZHANG ; Youpeng JIN ; Xiaodong ZHU ; Hong GAO ; Zipu LI ; Xiulan LU ; Hongjun MIAO ; Qiuyue ZHANG ; Yumei LI ; Weiguo YANG ; Chunyi LIU ; Bo LI ; Ying LI ; Zhenjiang BO ; Jianping CHU ; Xu WANG ; Guoping LU
Chinese Journal of Pediatrics 2018;56(12):929-932
Objective:
To survey the conduction and evaluate the effectiveness of extracorporeal membrane oxygenation (ECMO) therapy in pediatric intensive care unit (PICU) in China mainland.
Methods:
In a questionnaire-based survey, we retrospectively reviewed the application of ECMO in children's hospital and general hospital in China mainland to summarize and analyze the categories of diseases and prognosis of children treated with ECMO therapy.
Results:
By December 31, 2017, a total of 23 hospitals using ECMO, including 22 tertiary referral hospitals and 1 secondary hospital, among which 16 were children′s hospitals and 7 were general hospitals. Thirty-seven ECMO equipment was available. A total of 518 patients treated with ECMO, within whom 323 (62.4%) successfully weaned from ECMO and 262 (50.6%) survived to discharge. Among 375 pediatric patients, 233 (62.1%) were successfully weaned from ECMO and 186 (49.6%) survived to discharge. Among 143 newborn patients, 90 (62.9%) successfully weaned from ECMO, 76 (53.1%) survived to discharge. ECMO was applied in veno-arterial (VA) mode to 501 (96.7%) patients, veno-venous (VV) mode to 14 (2.7%) patients, and VV-VA conversion mode to 3 (0.6%) patients. Sixty-nine patients required extracorporeal cardiopulmonary resuscitation (ECPR), including 20 newborn patients (29.0%) and 38 pediatric patients (71.0%), who were all with cardiovascular disease. Neonatal respiratory distress syndrome (26/61), persistent pulmonary hypertension of the newborn (PPHN) (12/61), and meconium aspiration syndrome (MAS) (11/61) are the most common pulmonary diseases in newborn patients; among whom, infants with PPHN had highest survival rate (10/12), followed by MAS (9/11). Among newborn patients with cardiovascular diseases, those who admitted were after surgery for congenital cardiac disease were the most common (54/82), while those with septic shock had the highest survival rate (2/3). In pediatric pulmonary diseases, acute respiratory distress syndrome was the most common (42/93), while plastic bronchitis was with the highest survival rate (4/4), followed by viral pneumonia (13/16). Among pediatric cardiovascular diseases, congenital cardiac defect was the most common (124/282), while fulminant myocarditis had the highest survival rate (54/77).
Conclusion
The application of ECMO as a rescue therapy for children with severe cardiopulmonary failure has dramatically developed in China mainland.